University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in Scotland

Simple item page
dc.contributor.authorMcKeigue, P. M.
dc.contributor.authorPorter, D.
dc.contributor.authorHollick, R. J.
dc.contributor.authorRalston, S. H.
dc.contributor.authorMcAllister, D. A.
dc.contributor.authorColhoun, H. M.
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Research Excellence in Musculoskeletal Health: Collaborate. Innovate. Translate.en
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.date.accessioned2023-09-26T13:58:02Z
dc.date.available2023-09-26T13:58:02Z
dc.date.issued2023
dc.descriptionFunding Information: No specific funding was received for this study. We thank Jen Bishop, Ciara Gribben, and David Caldwell for undertaking the linkage analysis in Public Health Scotland, and staff from the rheumatology service in the contributing centres for preparing the list of patients receiving these treatments.en
dc.description.statusPeer revieweden
dc.format.extent6
dc.format.extent579583
dc.identifier276514672
dc.identifier3e969d97-d6a8-4110-8d9c-fb48c1ef3bba
dc.identifier85130276726
dc.identifier35549809
dc.identifier.citationMcKeigue, P M, Porter, D, Hollick, R J, Ralston, S H, McAllister, D A & Colhoun, H M 2023, 'Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in Scotland', Scandinavian Journal of Rheumatology, vol. 52, no. 4, pp. 412-417. https://doi.org/10.1080/03009742.2022.2063376en
dc.identifier.doi10.1080/03009742.2022.2063376
dc.identifier.issn0300-9742
dc.identifier.otherORCID: /0000-0001-6558-7189/work/143412784
dc.identifier.urihttps://hdl.handle.net/2164/21761
dc.identifier.urlhttps://www.scopus.com/pages/publications/85130276726en
dc.language.isoeng
dc.relation.ispartofScandinavian Journal of Rheumatologyen
dc.subjectR Medicine (General)en
dc.subjectRheumatologyen
dc.subjectImmunology and Allergyen
dc.subjectImmunologyen
dc.subjectSupplementary Dataen
dc.subjectGithuben
dc.subject.lccR1en
dc.titleRisk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in Scotlanden
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
McKeigue_etal_SJoR_Risk_of_Severe_VOR.pdf
Size:
566 KB
Format:
Adobe Portable Document Format
Download

Collections

All research

The Sir Duncan Rice Library

University of Aberdeen

Bedford Road

Aberdeen

AB24 3AA


Tel: +44 (0)1224 273330

Email: library@abdn.ac.uk

Share and keep up to date


FacebookTwitterWordpress